76.97
1.45%
1.10
시간 외 거래:
69.98
-6.99
-9.08%
전일 마감가:
$75.87
열려 있는:
$75.89
하루 거래량:
1.82M
Relative Volume:
0.99
시가총액:
$14.68B
수익:
$4.08B
순이익/손실:
$32.48M
주가수익비율:
40.72
EPS:
1.89
순현금흐름:
$16.80M
1주 성능:
-5.59%
1개월 성능:
+15.94%
6개월 성능:
+34.80%
1년 성능:
+41.83%
인사이트 코퍼레이션 Stock (INCY) Company Profile
명칭
Incyte Corp
전화
(302) 498-6700
주소
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE
INCY을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
INCY | 76.97 | 14.68B | 4.08B | 32.48M | 16.80M | 1.89 |
VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
인사이트 코퍼레이션 Stock (INCY) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-02-14 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
2023-12-13 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
2023-12-04 | 업그레이드 | Guggenheim | Neutral → Buy |
2023-11-21 | 다운그레이드 | Goldman | Buy → Neutral |
2023-07-25 | 개시 | Citigroup | Buy |
2023-05-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
2023-04-10 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2023-03-24 | 업그레이드 | SVB Securities | Underperform → Market Perform |
2023-01-31 | 개시 | Piper Sandler | Overweight |
2022-08-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2022-08-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
2022-07-28 | 개시 | Wells Fargo | Equal Weight |
2022-02-09 | 다운그레이드 | SVB Leerink | Mkt Perform → Underperform |
2022-01-18 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
2021-07-20 | 업그레이드 | The Benchmark Company | Hold → Buy |
2021-02-10 | 다운그레이드 | SVB Leerink | Mkt Perform → Underperform |
2021-01-07 | 개시 | Truist | Buy |
2021-01-04 | 업그레이드 | Guggenheim | Neutral → Buy |
2020-06-16 | 개시 | The Benchmark Company | Hold |
2020-05-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2020-04-29 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2020-04-01 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2020-03-24 | 재개 | William Blair | Outperform |
2020-03-13 | 업그레이드 | BofA/Merrill | Neutral → Buy |
2020-02-04 | 재개 | BofA/Merrill | Neutral |
2020-01-03 | 재확인 | BMO Capital Markets | Market Perform |
2020-01-03 | 다운그레이드 | Mizuho | Buy → Neutral |
2020-01-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
2019-10-03 | 개시 | Mizuho | Buy |
2019-09-12 | 개시 | BMO Capital Markets | Market Perform |
2019-09-05 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
2019-09-05 | 재개 | Morgan Stanley | Equal-Weight |
2019-09-05 | 업그레이드 | Oppenheimer | Perform → Outperform |
2019-05-21 | 개시 | Credit Suisse | Neutral |
2019-05-03 | 다운그레이드 | Barclays | Overweight → Equal Weight |
2019-04-11 | 개시 | Stifel | Hold |
2019-04-03 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2019-01-24 | 업그레이드 | William Blair | Mkt Perform → Outperform |
모두보기
인사이트 코퍼레이션 주식(INCY)의 최신 뉴스
Seizert Capital Partners LLC Has $6.24 Million Position in Incyte Co. (NASDAQ:INCY) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Sells 49,495 Shares of Incyte Co. (NASDAQ:INCY) - MarketBeat
Here’s How Jakafi’s Patent Expiry Impacts Incyte Corporation’s (INCY) Growth Prospects - Insider Monkey
Incyte Co. (NASDAQ:INCY) Shares Purchased by Mizuho Securities USA LLC - MarketBeat
Incyte Co. (NASDAQ:INCY) Shares Sold by Principal Financial Group Inc. - MarketBeat
Incyte Corp. stock outperforms competitors despite losses on the day - MarketWatch
KBC Group NV Reduces Position in Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte's SWOT analysis: stock faces patent cliff as pipeline progresses By Investing.com - Investing.com Australia
Incyte to Present at Upcoming Investor Conference - Yahoo Finance
INCY (Incyte) Cash Flow from Operations : $102 Mil (TTM As of Sep. 2024) - GuruFocus.com
Incyte's SWOT analysis: stock faces patent cliff as pipeline progresses - Investing.com
Anal Cancer Market Revenue to Expand Significantly by 2034, States DelveInsight Report | Incyte Corp, BioMimetix, Inovio Pharma, Merck Sharp & Dohme, Dustin Deming, Advaxis - The Globe and Mail
Anal Cancer Market Revenue to Expand Significantly by 2034, - openPR
State of New Jersey Common Pension Fund D Reduces Stock Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte Co. (NASDAQ:INCY) Shares Sold by Amalgamated Bank - MarketBeat
Los Angeles Capital Management LLC Lowers Stock Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat
Chronic Hand Eczema Pipeline Update 2024: FDA Approvals, - openPR
Applied Finance Capital Management LLC Reduces Stock Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Barry P. Flannelly Sells 3,680 Shares of Incyte Co. (NASDAQ:INCY) Stock - MarketBeat
Incyte Insider Sold Shares Worth $293,210, According to a Recent SEC Filing - Marketscreener.com
Incyte Co. (NASDAQ:INCY) Stock Holdings Lowered by ARK Investment Management LLC - MarketBeat
Incyte Corp. stock outperforms competitors on strong trading day - MarketWatch
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Van ECK Associates Corp Has $8.79 Million Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat
Greenwood Capital Associates LLC Acquires Shares of 6,546 Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte Corporation: Will Their Focus on Oncological Innovations Pay Off?Major Drivers - Smartkarma
Incyte stock soars to 52-week high, hits $76.58 - Investing.com
Robeco Institutional Asset Management B.V. Buys 70,596 Shares of Incyte Co. (NASDAQ:INCY) - MarketBeat
NJ Judge Blocks Sun Pharma From Launching Hair Loss Drug - Law360
Incyte (NASDAQ:INCY) Sets New 52-Week HighWhat's Next? - MarketBeat
Incyte Corp (INCY)'s Winning Formula: Financial Metrics and Comp - GuruFocus.com
Incyte Co. (NASDAQ:INCY) Stock Holdings Trimmed by State of Alaska Department of Revenue - MarketBeat
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday - MSN
Incyte (NASDAQ:INCY) Posts Quarterly Earnings Results, Misses Expectations By $0.12 EPS - MarketBeat
INCY Q3 Earnings Miss Estimates, Revenues Beat on Higher Product Sales - MSN
Incyte Corporation (NASDAQ:INCY) Q3 2024 Earnings Call Transcript - Insider Monkey
14,631 Shares in Incyte Co. (NASDAQ:INCY) Acquired by Integrated Advisors Network LLC - MarketBeat
Incyte Corp (INCY) Q3 2024 Earnings Call Highlights: Strong Reve - GuruFocus.com
Earnings call: Incyte reports robust growth and pipeline progress - Investing.com
Incyte's Jakafi Demand Is Strong, Analyst Upgrades Stock - Yahoo Finance
Incyte Raises Jakafi Sales Forecast, Surpassing Expectations - Finimize
Incyte (NASDAQ:INCY) Price Target Raised to $71.00 - MarketBeat
Incyte shares target upgraded, outperform rating on strong Q3 sales - Investing.com
Incyte stock target raised, underperform rating held on Jakafi revenue outlook - Investing.com
Incyte shares target raised, rating held on strong 3Q results - Investing.com
Incyte to Present at Upcoming Investor Conferences - Yahoo Finance
Incyte Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Incyte stock sees upside with strong Jakafi performance and robust pipeline—Citi - Investing.com
Incyte (INCY) PT Raised to $87 at Leerink Partners - StreetInsider.com
Incyte (INCY) PT Raised to $97 at Citi - StreetInsider.com
인사이트 코퍼레이션 (INCY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):